ARKW vs IBB
ARK Next Generation Internet ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.76% for ARKW.
- • ARKW pays a higher dividend yield (1.71%).
Side-by-side metrics
| Metric | ARKW | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.76% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.71% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $1.67B | $7.95B |
YTD return | -1.21% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.26 | 0.74 |
P/E ratio | 45.89 | 23.72 |
Last price | $145.77 | $170.10 |
Inception | — | — |
Issuer | ARK | iShares |
ARKW top holdings
| AMD | Advanced Micro Devices Inc | 8.80% |
| TSLA | Tesla Inc | 8.61% |
| HOOD | Robinhood Markets Inc Class A | 4.64% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.51% |
| AMZN | Amazon.com Inc | 4.19% |
| ROKU | Roku Inc Class A | 4.10% |
| CRWV | CoreWeave Inc Ordinary Shares - Class A | 4.06% |
| GOOG | Alphabet Inc Class C | 3.93% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 3.93% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About ARKW
ARKW (ARK Next Generation Internet ETF) is Active strategy targeting next-gen internet companies. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.76%, a dividend yield of 1.71%. Its largest holding is Advanced Micro Devices Inc (AMD), which represents 8.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 19.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.